Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  HIV Infection

  Free Subscription


10.04.2017

3 AIDS
2 AIDS Res Hum Retroviruses
2 Antivir Ther
1 BMC Pediatr
1 Br J Dermatol
18 Clin Infect Dis
2 HIV Med
1 Immunology
2 J Acquir Immune Defic Syndr
3 J Infect Dis
2 J Med Virol
3 J Virol
1 JAMA
1 Lancet HIV
1 MMWR Morb Mortal Wkly Rep
1 Neurology
1 Pediatr Infect Dis J
1 PLoS Biol
1 PLoS Med
10 PLoS One
1 Vaccine


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    AIDS

  1. LEPIK KJ, Harrigan PR, Yip B, Wang L, et al
    Emergent drug resistance with integrase strand transfer inhibitor-based regimens: Incidence and risk factors.
    AIDS. 2017 Apr 3. doi: 10.1097/QAD.0000000000001494.
    PubMed     Text format     Abstract available

  2. VAN BILSEN WP, van den Berg CH, Rijnders BJ, Brinkman K, et al
    Immune reconstitution inflammatory syndrome associated with toxoplasmic encephalitis in hiv-infected patients: a multicenter cohort study.
    AIDS. 2017 Apr 3. doi: 10.1097/QAD.0000000000001492.
    PubMed     Text format     Abstract available

  3. GONCIULEA A, Wang R, Althoff KN, Palella FJ, et al
    An Increased Rate of Fracture Occurs a Decade Earlier in HIV+ Compared to HIV- men in the Multicenter AIDS Cohort Study (MACS).
    AIDS. 2017 Apr 3. doi: 10.1097/QAD.0000000000001493.
    PubMed     Text format     Abstract available


    AIDS Res Hum Retroviruses

  4. AHUKA-MUNDEKE S, Mbala-Kingebeni P, Ndimbo-Kumogo SP, Foncelle C, et al
    Full Genome Characterization of a New Simian Immune Deficiency Virus Lineage in a Naturally Infected Cercopithecus ascanius whitesidei in the Democratic Republic of Congo Reveals High Genetic Diversity Among Red-Tailed Monkeys in Central and Eastern A
    AIDS Res Hum Retroviruses. 2017 Apr 6. doi: 10.1089/aid.2017.0027.
    PubMed     Text format     Abstract available

  5. CHEN I, Zhang Y, Cummings V, Cloherty GA, et al
    Analysis of HIV Integrase Resistance in Black Men Who Have Sex with Men in the United States.
    AIDS Res Hum Retroviruses. 2017 Apr 6. doi: 10.1089/aid.2017.0005.
    PubMed     Text format     Abstract available


    Antivir Ther

  6. VAN LUIN M, Ter Beest G, Wijnberger LE, Swanink CM, et al
    Zidovudine continuous infusion in an HIV-infected pregnant woman with a phobia of swallowing pills.
    Antivir Ther. 2017 Apr 3. doi: 10.3851/IMP3164.
    PubMed     Text format     Abstract available

  7. HANKINS CA, Koulla-Shiro S, Kilmarx P, Ferrari G, et al
    Ending AIDS as a public health threat by 2030: Scientific Developments from the 2016 INTEREST Conference in Yaounde, Cameroon.
    Antivir Ther. 2017 Apr 7. doi: 10.3851/IMP3165.
    PubMed     Text format     Abstract available


    BMC Pediatr

  8. SUNGUYA BF, Mlunde LB, Urassa DP, Poudel KC, et al
    Improving feeding and growth of HIV-positive children through nutrition training of frontline health workers in Tanga, Tanzania.
    BMC Pediatr. 2017;17:94.
    PubMed     Text format     Abstract available


    Br J Dermatol

  9. COMBALIA A, To-Figueras J, Laguno M, Martinez-Rebollar M, et al
    Direct-acting antivirals for hepatitis C virus induce a rapid clinical and biochemical remission of porphyria cutanea tarda.
    Br J Dermatol. 2017 Mar 29. doi: 10.1111/bjd.15502.
    PubMed     Text format     Abstract available


    Clin Infect Dis

  10. NOSKA AJ, Belperio PS, Loomis TP, O'Toole TP, et al
    Prevalence of HIV, HCV and HBV among Homeless and Non-homeless United States Veterans.
    Clin Infect Dis. 2017 Apr 1. doi: 10.1093.
    PubMed     Text format     Abstract available

  11. ADACHI K, Xu J, Ank B, Watts DH, et al
    Cytomegalovirus Urinary Shedding in HIV-infected Pregnant Women and Congenital Cytomegalovirus Infection.
    Clin Infect Dis. 2017 Mar 22. doi: 10.1093.
    PubMed     Text format     Abstract available

  12. BECOFSKY K, Wing EJ, McCaffery J, Bodreau M, et al
    A Randomized, Controlled Trial of a Behavioral Weight Loss Program for HIV-Infected Patients.
    Clin Infect Dis. 2017 Mar 23. doi: 10.1093.
    PubMed     Text format     Abstract available

  13. HWANG C, Schurmann D, Sobotha C, Boffito M, et al
    Antiviral Activity, Safety, and Exposure-Response relationships of GSK3532795, a Second-Generation HIV-1 Maturation Inhibitor, administered as Monotherapy or in Combination with Atazanavir+/-Ritonavir in a Phase 2a Randomized, Dose-Ranging, Controlled
    Clin Infect Dis. 2017 Mar 23. doi: 10.1093.
    PubMed     Text format     Abstract available

  14. WYLES D, Brau N, Kottilil S, Daar ES, et al
    Sofosbuvir and Velpatasvir for the Treatment of HCV in Patients Coinfected with HIV-1: an Open-Label, Phase 3 Study.
    Clin Infect Dis. 2017 Mar 29. doi: 10.1093.
    PubMed     Text format     Abstract available

  15. JANSSEN S, Schutz C, Ward A, Nemes E, et al
    Mortality in Severe HIV-TB Associates with Innate Immune Activation and Dysfunction of Monocytes.
    Clin Infect Dis. 2017 Mar 24. doi: 10.1093.
    PubMed     Text format     Abstract available

  16. MADHI SA, Nunes M, Weinberg A, Kuwanda L, et al
    Contribution of serology assays in the evaluation of influenza virus infection rates and vaccine efficacy in pregnant women: Report from randomized controlled trials.
    Clin Infect Dis. 2017 Mar 21. doi: 10.1093.
    PubMed     Text format     Abstract available

  17. THOMAS M, Hopkins C, Duffy E, Lee D, et al
    Association of the HLA-B*53:01 Allele With Drug Reaction With Eosinophilia and Systemic Symptoms (DRESS) Syndrome During Treatment of HIV Infection With Raltegravir.
    Clin Infect Dis. 2017 Mar 21. doi: 10.1093.
    PubMed     Text format     Abstract available

  18. GOURLAY A, Noori T, Pharris A, Axelsson M, et al
    The HIV continuum of care in European Union countries in 2013: data and challenges.
    Clin Infect Dis. 2017 Mar 20. doi: 10.1093.
    PubMed     Text format     Abstract available

  19. BUTT AA, Ren Y, Lo Re V 3rd, Taddei T, et al
    Comparing Child-Pugh, MELD and FIB-4 to Predict Clinical Outcomes in HCV-Infected Persons: Results from ERCHIVES.
    Clin Infect Dis. 2017 Mar 22. doi: 10.1093.
    PubMed     Text format     Abstract available

  20. CURLIN ME, Gvetadze R, Leelawiwat W, Martin M, et al
    Analysis of false-negative HIV rapid tests performed on oral fluid in three international clinical research studies.
    Clin Infect Dis. 2017 Mar 20. doi: 10.1093.
    PubMed     Text format     Abstract available

  21. GUARALDI G, Rockwood K
    Geriatric-HIV medicine is born.
    Clin Infect Dis. 2017 Apr 6. doi: 10.1093.
    PubMed     Text format    

  22. UNDERWOOD J, Cole JH, Caan M, De Francesco D, et al
    Grey and white matter abnormalities in treated HIV-disease and their relationship to cognitive function.
    Clin Infect Dis. 2017 Apr 6. doi: 10.1093.
    PubMed     Text format     Abstract available

  23. WALENSKY RP, Del Rio C, Armstrong WS
    Charting the Future of Infectious Disease: Anticipating and Addressing the Supply and Demand Mismatch.
    Clin Infect Dis. 2017 Apr 6. doi: 10.1093.
    PubMed     Text format    

  24. SINGH HK, Del Carmen T, Freeman R, Glesby MJ, et al
    From One Syndrome to Many: Incorporating Geriatric Consultation into HIV Care.
    Clin Infect Dis. 2017 Apr 6. doi: 10.1093.
    PubMed     Text format     Abstract available

  25. ADAORA A A, Cole SR, Eron JJ
    US Black Women and HIV Prevention: Time for New Approaches to Clinical Trials.
    Clin Infect Dis. 2017 Apr 5. doi: 10.1093.
    PubMed     Text format     Abstract available

  26. SOHN AH, Hazra R
    Old Problems for New Providers: Managing the Postpediatric HIV Generation.
    Clin Infect Dis. 2017 Mar 24. doi: 10.1093.
    PubMed     Text format    

  27. JOHS NA, Wu K, Tassiopoulos K, Koletar SL, et al
    Disability among Middle-Aged and Older Persons with HIV Infection.
    Clin Infect Dis. 2017 Mar 27. doi: 10.1093.
    PubMed     Text format     Abstract available


    HIV Med

  28. MARZEL A, Shilaih M, Turk T, Campbell NK, et al
    Mining for pairs: shared clinic visit dates identify steady HIV-positive partnerships.
    HIV Med. 2017 Apr 4. doi: 10.1111/hiv.12507.
    PubMed     Text format     Abstract available


  29. Abstracts of the 23rd Annual Conference of the British HIV Association (BHIVA), Liverpool, UK, 4-7 April 2017.
    HIV Med. 2017;18 Suppl 1:3-70.
    PubMed     Text format    


    Immunology

  30. AMBADA GN, Ntsama CE, Nji NN, Ngu LN, et al
    Phenotypic characterization of regulatory T cells from antiretroviral naive HIV-1 infected people.
    Immunology. 2017 Apr 4. doi: 10.1111/imm.12738.
    PubMed     Text format     Abstract available


    J Acquir Immune Defic Syndr

  31. CUNNINGHAM WE, Ford CL, Kinsler JJ, Seiden D, et al
    Effects of a Laboratory Health Information Exchange Intervention on Antiretroviral Therapy Use, Viral Suppression and Racial/Ethnic Disparities.
    J Acquir Immune Defic Syndr. 2017 Mar 25. doi: 10.1097/QAI.0000000000001385.
    PubMed     Text format     Abstract available

  32. PATEL RR, Chan PA, Mena L, Crowley JS, et al
    Time to make the jump: Translating HIV pre-exposure prophylaxis research into real-world public health impact.
    J Acquir Immune Defic Syndr. 2017 Apr 4. doi: 10.1097/QAI.0000000000001386.
    PubMed     Text format    


    J Infect Dis

  33. VERMUND SH
    The Continuum of HIV Care in the Urban United States: Black Men Who Have Sex With Men (MSM) Are Less Likely Than White MSM to Receive Antiretroviral Therapy.
    J Infect Dis. 2017 Mar 29. doi: 10.1093.
    PubMed     Text format    

  34. HOOTS BE, Finlayson TJ, Wejnert C, Paz-Bailey G, et al
    Updated Data on Linkage to Human Immunodeficiency Virus Care and Antiretroviral Treatment Among Men Who Have Sex With Men-20 Cities, United States.
    J Infect Dis. 2017 Mar 29. doi: 10.1093.
    PubMed     Text format     Abstract available

  35. RAHIMY E, Li FY, Hagberg L, Fuchs D, et al
    Blood-Brain Barrier Disruption Is Initiated During Primary HIV Infection and Not Rapidly Altered by Antiretroviral Therapy.
    J Infect Dis. 2017 Mar 29. doi: 10.1093.
    PubMed     Text format     Abstract available


    J Med Virol

  36. HUSAIN M, Sharma U, Gupta P, Singhal M, et al
    Comparative genetic variability in HIV-1 subtype C nef gene in early age groups of infants.
    J Med Virol. 2017 Mar 31. doi: 10.1002/jmv.24820.
    PubMed     Text format     Abstract available

  37. SNELL LB, Smith C, Chaytor S, McRae K, et al
    Screening for potential susceptibility to rubella in an antenatal population: A multivariate analysis.
    J Med Virol. 2017 Mar 31. doi: 10.1002/jmv.24818.
    PubMed     Text format     Abstract available


    J Virol

  38. RANKOVIC S, Varadarajan J, Ramalho R, Aiken C, et al
    Reverse transcription mechanically initiates HIV-1 capsid disassembly.
    J Virol. 2017 Apr 5. pii: JVI.00289-17. doi: 10.1128/JVI.00289.
    PubMed     Text format     Abstract available

  39. YI F, Guo J, Dabbagh D, Spear M, et al
    Discovery of Novel Small Molecule Inhibitors of LIM Domain Kinase for Inhibiting HIV-1.
    J Virol. 2017 Apr 5. pii: JVI.02418-16. doi: 10.1128/JVI.02418.
    PubMed     Text format     Abstract available

  40. RINGE RP, Ozorowski G, Yasmeen A, Cupo A, et al
    Improving the expression and purification of soluble, recombinant native-like HIV-1 envelope glycoprotein trimers by targeted sequence changes.
    J Virol. 2017 Apr 5. pii: JVI.00264-17. doi: 10.1128/JVI.00264.
    PubMed     Text format     Abstract available


    JAMA

  41. VOLBERDING PA
    How to Survive a Plague: The Next Great HIV/AIDS History.
    JAMA. 2017;317:1298-1299.
    PubMed     Text format    


    Lancet HIV

  42. NOSYK B, Zang X, Min JE, Krebs E, et al
    Relative effects of antiretroviral therapy and harm reduction initiatives on HIV incidence in British Columbia, Canada, 1996-2013: a modelling study.
    Lancet HIV. 2017 Mar 30. pii: S2352-3018(17)30045.
    PubMed     Text format     Abstract available


    MMWR Morb Mortal Wkly Rep

  43. CUFFE KM, Esie P, Leichliter JS, Gift TL, et al
    HIV Services Provided by STD Programs in State and Local Health Departments - United States, 2013-2014.
    MMWR Morb Mortal Wkly Rep. 2017;66:355-358.
    PubMed     Text format     Abstract available


    Neurology

  44. SEILER A, You SJ, Wagner M, Klein JC, et al
    Teaching NeuroImages: HIV-associated cerebral vasculopathy with multiple nodular aneurysms.
    Neurology. 2017;88:e143-e144.
    PubMed     Text format    


    Pediatr Infect Dis J

  45. DZIUBAN EJ, DeVos J, Ngeno B, Ngugi E, et al
    High Prevalence of Abacavir-Associated L74V/I Mutations in Kenyan Children Failing Antiretroviral Therapy.
    Pediatr Infect Dis J. 2017 Apr 5. doi: 10.1097/INF.0000000000001597.
    PubMed     Text format     Abstract available


    PLoS Biol

  46. DELEON O, Hodis H, O'Malley Y, Johnson J, et al
    Accurate predictions of population-level changes in sequence and structural properties of HIV-1 Env using a volatility-controlled diffusion model.
    PLoS Biol. 2017;15:e2001549.
    PubMed     Text format     Abstract available


    PLoS Med

  47. GRANICH R, Gupta S, Hall I, Aberle-Grasse J, et al
    Status and methodology of publicly available national HIV care continua and 90-90-90 targets: A systematic review.
    PLoS Med. 2017;14:e1002253.
    PubMed     Text format     Abstract available


    PLoS One

  48. SIEFRIED KJ, Mao L, Kerr S, Cysique LA, et al
    Socioeconomic factors explain suboptimal adherence to antiretroviral therapy among HIV-infected Australian adults with viral suppression.
    PLoS One. 2017;12:e0174613.
    PubMed     Text format     Abstract available

  49. WAHED T, Alam A, Sultana S, Alam N, et al
    Sexual and reproductive health behaviors of female sex workers in Dhaka, Bangladesh.
    PLoS One. 2017;12:e0174540.
    PubMed     Text format     Abstract available

  50. CHEREAU F, Madec Y, Sabin C, Obel N, et al
    Impact of CD4 and CD8 dynamics and viral rebounds on loss of virological control in HIV controllers.
    PLoS One. 2017;12:e0173893.
    PubMed     Text format     Abstract available

  51. KACZMAREK DJ, Kokordelis P, Kramer B, Glassner A, et al
    Alterations of the NK cell pool in HIV/HCV co-infection.
    PLoS One. 2017;12:e0174465.
    PubMed     Text format     Abstract available

  52. LOOS J, Nostlinger C, Vuylsteke B, Deblonde J, et al
    First HIV prevalence estimates of a representative sample of adult sub-Saharan African migrants in a European city. Results of a community-based, cross-sectional study in Antwerp, Belgium.
    PLoS One. 2017;12:e0174677.
    PubMed     Text format     Abstract available

  53. NYONGESA MK, Sigilai A, Hassan AS, Thoya J, et al
    A mixed methods approach to adapting and evaluating the functional assessment of HIV infection (FAHI), Swahili version, for use with low literacy populations.
    PLoS One. 2017;12:e0175021.
    PubMed     Text format     Abstract available

  54. MOSS JA, Baum MM, Easley JT, Cox DM, et al
    An intravaginal ring for real-time evaluation of adherence to therapy.
    PLoS One. 2017;12:e0174729.
    PubMed     Text format     Abstract available

  55. PAQUIN-PROULX D, Greenspun BC, Costa EA, Segurado AC, et al
    MAIT cells are reduced in frequency and functionally impaired in human T lymphotropic virus type 1 infection: Potential clinical implications.
    PLoS One. 2017;12:e0175345.
    PubMed     Text format     Abstract available

  56. VILLAR-GARCIA J, Guerri-Fernandez R, Moya A, Gonzalez A, et al
    Impact of probiotic Saccharomyces boulardii on the gut microbiome composition in HIV-treated patients: A double-blind, randomised, placebo-controlled trial.
    PLoS One. 2017;12:e0173802.
    PubMed     Text format     Abstract available

  57. HAHN F, Schmalen A, Setz C, Friedrich M, et al
    Proteolysis of mature HIV-1 p6 Gag protein by the insulin-degrading enzyme (IDE) regulates virus replication in an Env-dependent manner.
    PLoS One. 2017;12:e0174254.
    PubMed     Text format     Abstract available


    Vaccine

  58. TANG X, Guo J, Cheng L, Sun C, et al
    Single N277A substitution in C2 of simian immunodeficiency virus envelope influences vaccine-elicited CD4i neutralizing and anti-V2 antibody responses.
    Vaccine. 2017 Mar 30. pii: S0264-410X(17)30389.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO HIV Infection is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: